<DOC>
	<DOCNO>NCT00403286</DOCNO>
	<brief_summary>The purpose study determine appropriate dose fluticasone propionate/formoterol fumarate close Advair Diskus ( fluticasone propionate/salmeterol xinafoate use pulmonary function , safety , level study drug blood plasma patient chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>A Dose-Finding Study Evaluating Safety Efficacy Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Diagnosis COPD Female childbearing potential use adequate birth control Smoker exsmoker history least 10 year smoke least one pack cigarettes per day Meet lung function requirement Diagnosis asthma Other significant disease COPD Pregnant lactate female Female planning become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Chronic</keyword>
	<keyword>Obstructive</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Dose-finding</keyword>
</DOC>